Xalkori and Leukopenia - a phase IV clinical study of FDA data

Summary:

Leukopenia is reported as a side effect among people who take Xalkori (crizotinib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Avastin, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Leukopenia when taking Xalkori. It is created by eHealthMe based on reports of 9,640 people who have side effects when taking Xalkori from the FDA, and is updated regularly.

What is Xalkori?

Xalkori has active ingredients of crizotinib. eHealthMe is studying from 9,659 Xalkori users. Check the latest studies of Xalkori.

What is Leukopenia?

Leukopenia (less number of white blood cells in blood) is found to be associated with 1,684 drugs and 2,289 conditions by eHealthMe. Check the latest studies of Leukopenia.

On Jul, 13, 2026

9,640 people reported to have side effects when taking Xalkori.
Among them, 28 people (0.29%) have Leukopenia.

Among these 28 people:

How long have people been on Xalkori when they have Leukopenia? *

What is the gender of people who have Leukopenia when taking Xalkori? *

female: 72 %
male: 28 %

What is the age of people who have Leukopenia when taking Xalkori? *

What are other drugs people take besides Xalkori? *

What are other side effects people have besides Leukopenia? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 11 people, 39.29%
Disease Progression: 6 people, 21.43%
Liver Function Test Abnormal: 4 people, 14.29%
Nausea (feeling of having an urge to vomit): 4 people, 14.29%
Taste - Impaired: 3 people, 10.71%
Depression: 3 people, 10.71%
Pneumonia: 3 people, 10.71%
Nausea And Vomiting: 3 people, 10.71%
Weakness: 2 people, 7.14%
Herpes Zoster: 2 people, 7.14%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 8 people, 28.57%
Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 25.00%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 3 people, 10.71%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 2 people, 7.14%
Non-Small Cell Lung Cancer Stage Iv: 1 person, 3.57%
Anaplastic Large Cell Lymphoma T- And Null-Cell Types (t-cell or null-cell cancer, a type of blood cancer): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Xalkori and have Leukopenia?

- Check whether Leukopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalkori:

Xalkori (9,659 reports)

Leukopenia treatments and more:

Leukopenia (58,665 reports)

Browse all side effects of Xalkori:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukopenia:

Leukopenia (1,684 drugs)

Browse all the conditions that are associated with Leukopenia:

Leukopenia (2,289 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on crizotinib (the active ingredients of Xalkori) and Xalkori (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.